Global Women’s Health Drugs Market to 2024 – Influx of New Products Including Orilissa, Relugolix and Bremelanotide

Global Women’s Health Drugs Market to 2024 Research Report provides Key Marketed Products, Pipeline Landscape Assessment, Company Analysis and Positioning, Revenue and Market Share and Strategic Consolidations.

Pune, India - February 12, 2019 /MarketersMedia/ —

The women’s health therapy area covers medical disorders that affect females only, primarily disorders of the female reproductive system, including those associated with menstruation, conception, pregnancy, childbirth and menopause. Many of these disorders are highly prevalent among the female population.

The Women’s Health Market is relatively small considering the high prevalence of many women’s health indications. However, robust growth is projected over the forecast period due to the influx of a number of new products.

This report covers all indications within women’s health with a particular focus on five key indications: endometriosis, polycystic ovarian syndrome (PCOS), cervical intraepithelial neoplasia (CIN), menopausal disorders and infertility.

*Company Analysis and Positioning:
Revenue and Market Share Analysis by Company
1 Bayer AG - Company to Remain a Market Leader within Women’s Health
2 AbbVie Inc - Orilissa to Reach Blockbuster Status, Boosting Company’s Market Share
3 Allergan - Revenue Gains From Fibristal, Lo Loestrin Fe and Liletta to Offset Losses from Minastrin 24 Fe and Estrace
4 Merck & Co. - Company to Remain a Key Player Due to Growth of Gardasil/Gardasil 9
5 GlaxoSmithKline - Cervarix and Retosiban to Drive Strong Growth
6 Pfizer - How will patent expiration affect revenues for women’s health market?
7 TherapeuticsMD – Women’s Health Specialist to Gain Considerable Market Share by 2024

Get Discount on Global Women’s Health Drugs Market Research Report at https://www.reportsnreports.com/contacts/discount.aspx?name=1854865

Scope
- There are 277 pipeline products in active development for women’s health disorders. Which molecule types and molecular targets are most prominent within the pipeline?
- Merck&Co and Bayer currently represent leading companies within women’s health. Will they maintain this dominance over the forecast period?
- Gardasil, Mirena and Nuvaring and are among the most lucrative drugs within the women’s health market. Which of these will experience a considerable decline in revenue over the forecast period following loss of patent protection?
- The influx of a number of recent market entrants and late-stage pipeline products will have a considerable impact on the women’s health market over the forecast period. Which of these drugs are projected to achieve blockbuster status by 2024?
- In total, 246 licensing deals relating to women’s health products have been completed since 2006. Which types of assets attracted the largest deal values?

Direct Purchase of this Research Report at https://www.reportsnreports.com/purchase.aspx?name=1854865

Reasons to buy:
- Understand the current treatment landscape, with portfolios of key marketed products and a focus on historical and forecast sales patterns, and an overview of each drug’s mechanism of action.
- Analyze the women’s health pipeline through a comprehensive review of the pipeline segmented by stage of development, molecule type and molecular target.
- Consider market opportunities and potential risks by examining trends in clinical trial duration and size, as well as clinical trial failure rates.
- Predict growth in market size by examining multi-scenario forecasting trends from 2017 to 2024 and determine the contributions that different products and companies will make to this growth.
- Identify commercial opportunities in the women’s health deals landscape by analyzing trends in licensing and co-development deals.

Contact Info:
Name: Vishal Kalra
Email: Send Email
Organization: ReportsnReports
Website: https://www.reportsnreports.com/reports/1854865-global-womens-health-drugs-market-to-2024-influx-of-new-products-including-orilissa-relugolix-and-bremelanotide-to-diversify-landscape-and-drive-growth.html

Source URL: https://marketersmedia.com/global-womens-health-drugs-market-to-2024-influx-of-new-products-including-orilissa-relugolix-and-bremelanotide/481772

Source: MarketersMedia

Release ID: 481772

Latest News

Magic win 6th straight, top Heat 104-99 in East showdown

Mar 27, 2019

MIAMI — Nikola Vucevic scored 24 points and grabbed 16 rebounds, Jonathan Issac added 19 points and the Orlando Magic extended their longest winning streak in eight years to six games by topping the Miami Heat 104-99 on Tuesday night. D.J. Augustin scored 17 points and Aaron Gordon finished with 14 points and 10 rebounds for the Magic (37-38), who won the season series with Miami 3-1 and moved past the Heat (36-38) into eighth in the Eastern Conference playoff race. Evan Fournier scored 11 points for Orlando, which hasn't a winning streak this long since January 2011. Dion Waiters...

Pulisic scores, leaves with leg injury as US ties Chile 1-1

Mar 27, 2019

HOUSTON — Christian Pulisic became the youngest American to score 10 international goals, then limped off with a quadriceps injury during the United States' 1-1 exhibition tie against South American champion Chile on Tuesday night, a result that denied Gregg Berhalter's bid to become the first American coach to win his first four games. Pulisic scored in the fourth minute, bursting toward goal, running onto a one-touch pass from Gyasi Zardes and beating goalkeeper Gabriel Arias from just inside the penalty area. At 20 years, 189 days, Pulisic broke the American mark to double digits set in October 2010 by...

Ovechkin ends scoring drought, Capitals beat Hurricanes 4-1

Mar 27, 2019

WASHINGTON — Alex Ovechkin scored his NHL-leading 49th goal of the season to snap a four-game drought and help Washington beat the Carolina Hurricanes 4-1 on Tuesday night, increasing the Capitals' division lead. Ovechkin snapped a shot past Petr Mrazek for the go-ahead goal 4:31 into the third period for his third goal in 10 games. With his 656th career goal, Ovechkin tied Brendan Shanahan for 13th on the all-time list. T.J. Oshie and John Carlson also scored. Braden Holtby made 27 saves and Nicklas Backstrom added an empty-netter off a pass from Ovechkin as the Capitals won their second...

Shortstop Fernando Tatis Jr. makes Padres opening day roster

Mar 27, 2019

SAN DIEGO — Fernando Tatis Jr., the No. 2 overall prospect in baseball, has made the San Diego Padres' opening day roster, his father told The Associated Press on Tuesday night. Fernando Tatis, who played parts of 11 seasons in the big leagues, said he received a call from his son after the team's exhibition game in Seattle informing him of the team's decision. The senior Tatis said he was making arrangements to travel from San Pedro de Macoris, Dominican Republic, to San Diego for opening day Thursday against the San Francisco Giants. "He's very happy about it," Tatis said....

Celtics beat Cavs 116-106 without Kyrie to snap 4-game slide

Mar 27, 2019

CLEVELAND — Jayson Tatum and Marcus Smart each scored 21 points, and the Boston Celtics broke away from a fourth-quarter tie to defeat the Cleveland Cavaliers 116-106 on Tuesday night. Kyrie Irving (rest) didn't play for Boston, but the Celtics snapped a four-game losing streak and are 11-2 without their leading scorer. Al Horford had 19 points, including eight in the fourth quarter and the go-ahead layup early in the period. The Celtics ended the game with a 24-14 run also sparked by three-point plays from Smart and Marcus Morris to pull away. Collin Sexton led Cleveland with 24 points...

Get your 24-hour live updates here in Ultimate Sports Daily. We deliver content from all regions so that you won’t miss out on any single event.

Contact us: sales[at]ultimatesportsdaily.com